COXIR INTENSIVE EGF PEPTIDE SERUM

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
COXIR INTENSIVE EGF PEPTIDE SERUM
Generic name
NIACINAMIDE, ADENOSINE
Manufacturer
NOKSIBCHO cosmetic Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
03a97ef0-6ad1-47ef-a8f4-fd32fd02a199
SPL ID
4c2a01bc-c624-4feb-a024-e83aa1a5fefe
Version
1
Effective date
2021-07-14
Source export date
2026-10-27
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/977776a6cc37ec1c77259da8a93ae161850a3aa120341096e5a03428b84d016b/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:59:54
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only. Avoid contact with eyes. Keep out of reach of children. Discontinue use if signs of irritation appear.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.